US Patent 8158156 | US Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Actavis Inc

munit-sa-m-2025-04-14

Contact Supplier

Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

Contact Supplier

Suanfarma, at the Core of a Better Life.

Contact Supplier

xyz-pharma-m-2025-04-14

Contact Supplier

Actavis Inc

VISIT THE VIRTUAL BOOTH, Contact Details

VISIT THE VIRTUAL BOOTH
Review portfolio & marketing content
CONTACT DETAILS
Google Map, LinkedIn, Emails...

EVENTS

Webinars & Exhibitions

Webinars & Exhibitions

DIGITAL CONTENT

Interview #SpeakPharma, Vlog #PharmaReel, Data Compilation #PharmaFlow, 413 News #PharmaBuzz

Interview #SpeakPharma
Vlog #PharmaReel
Data Compilation #PharmaFlow
413 News #PharmaBuzz

ACTIVE PHARMA INGREDIENTS

110 All APIs, 104 USDMF, 7 CEP/COS, 1 JDMF, 3 EU WC, 1 NDC API, 1 VMF

110 All APIs
104 USDMF
7 CEP/COS
1 JDMF
3 EU WC
1 NDC API
1 VMF

FINISHED DOSAGE FORMULATIONS

3580 FDF Dossiers, 2335 FDA Orange Book, 1219 Europe, 2 Australia, 24 South Africa

3580 FDF Dossiers
2335 FDA Orange Book
1219 Europe
2 Australia
24 South Africa

EXCIPIENTS

1 All Excipients, 1 USDMF

1 All Excipients
1 USDMF

INSPECTIONS & REGISTRATIONS

76 FDA, 31 EDQM, 14 GDUFA

76 FDA
31 EDQM
14 GDUFA

Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

6 All

01 6ALPHARMA PHARMS

filter Patent Number Reset all filters

6 All

01 68158156

API Patent Reset all filters

6 All

01 6Blank

FDF Patent Reset all filters

6 All

01 6Blank

filter Expiration Date Reset all filters

6 All

01 62027-06-19

01

ALPHARMA PHARMS

MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE

MAGHREB PHARMA

Not Confirmed

ALPHARMA PHARMS

MAGHREB PHARMA

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2027-06-19

MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE

US Patent Number : 8158156

Drug Substance Claim :

Drug Product Claim :

Application Number : 22321

Patent Use Code : U-1510

Delist Requested :

Patent Use Description : MANAGEMENT OF PAIN SEV...

Patent Expiration Date : 2027-06-19

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

ALPHARMA PHARMS

MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE

MAGHREB PHARMA

Not Confirmed

ALPHARMA PHARMS

MAGHREB PHARMA

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2027-06-19

MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE

US Patent Number : 8158156

Drug Substance Claim :

Drug Product Claim :

Application Number : 22321

Patent Use Code : U-1510

Delist Requested :

Patent Use Description : MANAGEMENT OF PAIN SEV...

Patent Expiration Date : 2027-06-19

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

ALPHARMA PHARMS

MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE

MAGHREB PHARMA

Not Confirmed

ALPHARMA PHARMS

MAGHREB PHARMA

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2027-06-19

MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE

US Patent Number : 8158156

Drug Substance Claim :

Drug Product Claim :

Application Number : 22321

Patent Use Code : U-1510

Delist Requested :

Patent Use Description : MANAGEMENT OF PAIN SEV...

Patent Expiration Date : 2027-06-19

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

ALPHARMA PHARMS

MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE

MAGHREB PHARMA

Not Confirmed

ALPHARMA PHARMS

MAGHREB PHARMA

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2027-06-19

MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE

US Patent Number : 8158156

Drug Substance Claim :

Drug Product Claim :

Application Number : 22321

Patent Use Code : U-1510

Delist Requested :

Patent Use Description : MANAGEMENT OF PAIN SEV...

Patent Expiration Date : 2027-06-19

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

ALPHARMA PHARMS

MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE

MAGHREB PHARMA

Not Confirmed

ALPHARMA PHARMS

MAGHREB PHARMA

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2027-06-19

MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE

US Patent Number : 8158156

Drug Substance Claim :

Drug Product Claim :

Application Number : 22321

Patent Use Code : U-1510

Delist Requested :

Patent Use Description : MANAGEMENT OF PAIN SEV...

Patent Expiration Date : 2027-06-19

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

ALPHARMA PHARMS

MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE

MAGHREB PHARMA

Not Confirmed

ALPHARMA PHARMS

MAGHREB PHARMA

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2027-06-19

MORPHINE SULFATE; NALTREXONE HYDROCHLORIDE

US Patent Number : 8158156

Drug Substance Claim :

Drug Product Claim :

Application Number : 22321

Patent Use Code : U-1510

Delist Requested :

Patent Use Description : MANAGEMENT OF PAIN SEV...

Patent Expiration Date : 2027-06-19

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!